Analyst Price Targets — CMXHF
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 15, 2026 7:59 pm | Craig Wong-Pan | RBC Capital | $213.00 | $122.01 | TheFly | CSL upgraded to Outperform from Sector Perform at RBC Capital |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for CMXHF

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
Nearly a dozen drugmakers are reportedly slated to voluntarily sell their medications at lower prices under deals expected to be announced by President Donald Trump on Monday. The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
CNBC • Aug 31, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CMXHF.
Senate Trading
No Senate trades found for CMXHF.
U.S. House Trading
No House trades found for CMXHF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
